Megan Schwarz has a scientific background in biomedical sciences and has done research on molecular biology, cancer, immunology, virology, and assay development.
Prior to joining Jones Day in 2025, Megan completed her graduate studies at the Icahn School of Medicine, where her thesis comprised two distinct projects: the role of a novel oncogene in liver cancer and the development of a COVID-19 T cell assay. She has coauthored several peer-reviewed journal articles and reviews.
- Icahn School of Medicine at Mount Sinai (Ph.D. in Biomedical Sciences 2024); Barnard College (B.S. in Biology 2015)
- Registered to practice before the United States Patent and Trademark Office
发送前请注意
*Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice